Kudlu, India

Thirunelimada Devaiah Venu


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2021-2023

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Thirunelimada Devaiah Venu: Innovator in Pharmaceutical Chemistry

Introduction

Thirunelimada Devaiah Venu is a notable inventor based in Kudlu, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds. With a total of 2 patents to his name, Venu is recognized for his work in creating novel processes for drug preparation.

Latest Patents

Venu's latest patents include two significant inventions. The first patent is for Trisodium sacubitril valsartan and the process for its preparation. This invention provides a novel process for the preparation of crystalline Form B of N-(3-carboxyl-1-oxopropyl)-(4S)-(p-phenylphenylmethyl)-4-amino-2R-methyl butanoic acid ethyl ester sodium salt. The second patent focuses on Amorphous Trisodium Sacubitril Valsartan and the process for its preparation. This invention details crystalline Form B1 and B2 of the same compound, along with a novel process for its preparation.

Career Highlights

Thirunelimada Devaiah Venu is currently employed at Biocon Limited, a leading biopharmaceutical company. His work at Biocon has allowed him to contribute to the advancement of pharmaceutical innovations. Venu's expertise in drug formulation and preparation has positioned him as a valuable asset in the industry.

Collaborations

Throughout his career, Venu has collaborated with several talented individuals, including Palle Venkata Raghavendra Charyulu and Pratik Rameshchandra Patel. These collaborations have fostered a creative environment that encourages innovation and the development of new ideas.

Conclusion

Thirunelimada Devaiah Venu is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in drug preparation processes. His contributions, particularly through his patents, highlight his commitment to innovation in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…